期刊文献+

前列腺癌根治术后生化复发危险因素及预测研究进展 被引量:4

原文传递
导出
摘要 前列腺癌是欧美国家男性发病率最高的恶性肿瘤,其病死率仅次于肺癌。近年来随着我国人口平均寿命的延长,生活逐渐西方化,前列腺癌的发病率不断升高,同时随着诊断技术的不断提高,越来越多的前列腺癌早期得到诊治,因此也有越来越多的早期前列腺癌患者接受前列腺癌根治性外科手术。虽然早期前列腺癌通过根治手术能取得良好效果,但同时有一部分人群根治术后明显更容易出现复发,而生化复发[前列腺特异性抗原(PSA)升高]是提示前列腺癌复发的早期重要依据之一。因此研究前列腺癌根治术后复发的危险因素,有利于临床医师更好掌握手术适应证,
作者 林宁殊 夏溟
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第24期1721-1723,共3页 National Medical Journal of China
  • 相关文献

参考文献23

  • 1Bott SR.Management of recurrent disease after radical prostateetomy.Prostate Cancer Prostatic Dis,2004,7:211-216.
  • 2Polascik TJ,Oesterhng JE,Partin AW.Prostate specific antigen a decade of discovery-what we have learned and where we are going.J Urol,1999,162:293-306.
  • 3Moul JW.Prostate specific antigen only progression of prostate cancer.J Urol,2000,163:1632-1642.
  • 4Carroll PR.Nomngrams are superior to staging and risk grouping systems for identifying high-risk patients:preoperative apphcatian in prostate cancer.Urol Oncol,2003,21:484-485.
  • 5Kanety BR,Eustham JA,Reuter VE,et al.Feasibility of radical prostatectomy after neoadjuvant chemo hormonal therapy for patients with high risk or locally advanced prostate cancer:results of a phase Ⅰ/Ⅱ study.J Urol,2004,171:709-713.
  • 6Magheli A,Rais-Bahrami S,Carter HB,et al.Subclassification of clinical stage T1 prostate cancer:impact on biochemical recurrence following radical prostatectomy.J Urol,2007,178:1277-1280.
  • 7Froedland SJ,Wieder JA,Jack GS,et al.Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy glceaen score.J Urol,2002,168:110-115.
  • 8Houston R,Michael T,Blute J,et al.is the GPMS scoreing alporith for patients with prostate concer valid in the contempary era? J Urol,2007,178:459-463.
  • 9Pfitzenmaier J,Pahemik S,Tremmel T,et al.Positive surgical margins after radical prostatectomy:do they have an impact on biochemical or clinical progression? BJU Int,2008,102:1413-1418.
  • 10Boorjian SA,Thompson RH,Siddiqui S,et al.Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.J Urol,2007,178:864-870.

同被引文献53

  • 1李康,林一帆.评价判别模型诊断效果的ROC分析[J].中国卫生统计,1996,13(3):9-12. 被引量:22
  • 2Shi XB,Xue L,Yang J,et al.An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells.Proc Natl Acad Sci U S A,2007,104:19983-19988.
  • 3Lim LP,Glasner ME,Yekta S,et al.Vertebrate microRNA genes.Science,2003,299:1540.
  • 4Visone R,Croce CM.MiRNAs and cancer.Am J Pathol,2009,174:1131-1138.
  • 5Costinean S,Zanesi N,Pekarsky Y,et al.Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E (mu) -miR155 transgenic mice.Proc Natl Acad Sci U S A,2006,103:7024-7029.
  • 6Cimmino A,Calin CA,Fabbri M,et al.miR-15 and miR-16 induce apoptosis by targeting BCL2.Proc Natl Acad Sci U S A,2005,102:13944-13949.
  • 7Sassen S,Miska EA,Caldas C.MicroRNA:implications for cancer.Virchows Arch,2008,452:1-10.
  • 8Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009.CA Cancer J Clin,2009,59:225-249.
  • 9Sakr WA,Ward C,Grignon DJ,et al.Epidemiology and molecular biology of early prostatic neoplasia.Mol Urol,2000,4:109-113.
  • 10Feldman BJ,Feldman D.The development of androgenindependent prostate cancer.2001.p.34-45.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部